Skip to main content
TipRanks
Go Ultimate75% OFF

Shinpoong Pharmaceutical Co., Ltd. (019170) Stock Forecast & Price Target

See the Price Targets and Ratings of:

019170 Analyst Ratings

Currently, no data available

019170 Stock 12 Month Forecast

There Are No Analyst Ratings for 019170 In The Last 3 Months.

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for KR:019170
Price TargetArticle
TipRanks - PerPlexity₩7,933sell0.16%UpsideInitiated11/02/26
TipRanks - Anthropic₩8,267hold4.38%UpsideInitiated11/01/26
TipRanks - OpenAI₩8,392hold5.96%UpsideInitiated10/28/26
Stocks with the Highest Top Analyst Consensus in the General Sector
STDNStandard Nuclear
SKHYSK Hynix
ITGITG Inc. Class A
LIMENeutron Holdings, Inc.
EROCERock

Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Shinpoong Pharmaceutical Co., Ltd.

3 Months
PerPlexity General EU
PerPlexity General EUTipRanks - PerPlexity
Success Rate1/1 ratings generated profit
100%
Average Return
+5.00%

Copying PerPlexity General EU's trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +5.00% per trade.

1 Year
PerPlexity General EU
PerPlexity General EUTipRanks - PerPlexity
Success Rate1/1 ratings generated profit
100%
Average Return
+5.00%

Copying PerPlexity General EU's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +5.00% per trade.

2 Years
PerPlexity General EU
PerPlexity General EUTipRanks - PerPlexity
Success Rate1/1 ratings generated profit
100%
Average Return
+5.00%

Copying PerPlexity General EU's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +5.00% per trade.

019170 Analyst Recommendation Trends

00.511.52Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for 019170
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy00000
Buy00000
Hold00000
Sell00000
Strong Sell00000
total00000

In the current month, 019170 has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 019170 average Analyst price target in the past 3 months is ―.

019170 Financial Forecast

₩-151₩-82₩-13₩56₩125Q4 2025Q2 2026Q3 2026
Consensus₩-149.23

019170 Earnings Forecast

Next quarter’s earnings estimate for 019170 is -KRW 149.23 with a range of ― to ―. The previous quarter’s EPS was -KRW 149.23. Its overall industry beat the EPS estimate 50.49% of the time in the past 12 months.

₩54.5B₩56.9B₩59.2B₩61.5B₩63.9BQ4 2025Q2 2026Q3 2026
Consensus₩63.9B

019170 Sales Forecast

Next quarter’s sales forecast for 019170 is KRW 63.89B with a range of ― to ―. The previous quarter’s sales results were KRW 63.89B. Its overall industry beat sales estimates 63.25% of the time in the past 12 months.

019170 Stock Forecast FAQ

Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
What do analysts say about Shinpoong Pharmaceutical Co., Ltd.?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of Shinpoong Pharmaceutical Co., Ltd.?
To buy shares of KR:019170, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.